🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
SciVision Biotech Inc. (TPE:1786)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.35
-1.35 (-3.24%)
Nov 20, 2026, 1:30 PM CST

SciVision Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
571.03845.81706.02511.1587.02658.92
Short-Term Investments
79.979.999.9233.930.7136.92
Trading Asset Securities
220.18-----
Cash & Short-Term Investments
871.11925.71805.92745617.73695.84
Cash Growth
-9.24%14.86%8.18%20.60%-11.23%68.36%
Accounts Receivable
244.87242.14172.9495.1890.3478.37
Other Receivables
17.131.561.091.021.160.2
Receivables
262.01243.7174.0296.2191.4978.56
Inventory
91.9782.1572.2387.2595.8782.9
Prepaid Expenses
72.8446.3947.9415.4818.6521.7
Other Current Assets
0.46129.2366.359.9757.2946.24
Total Current Assets
1,2981,4271,1661,004881.03925.24
Property, Plant & Equipment
1,1741,2281,1761,1351,1841,246
Other Intangible Assets
1.81.41.682.152.673.38
Long-Term Deferred Tax Assets
6.827.145.0215.525.0431.33
Other Long-Term Assets
5.96.25.013.225.2356.48
Total Assets
2,4872,6702,3542,1602,0982,262

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7.8816.413.276.7514.025.46
Accrued Expenses
-113.91135.76102.5678.4-
Short-Term Debt
-0.51----
Current Portion of Long-Term Debt
381.07-134.79--303.37
Current Portion of Leases
10.2910.184.731.221.21.24
Current Income Taxes Payable
-2.3912.655.7713.97-
Current Unearned Revenue
10.011.552.687.020.71.71
Other Current Liabilities
157.4329.7133.1921.6919.79113.86
Total Current Liabilities
566.68174.65337.07144.99128.08425.64
Long-Term Debt
-373.59-323.84386.69300
Long-Term Leases
94.2100.8684.7222.8524.128.48
Pension & Post-Retirement Benefits
3.926.418.1418.9225.4735.16
Long-Term Deferred Tax Liabilities
2.950.494.350.030.05-
Other Long-Term Liabilities
24.8633.3523.1523.0322.9122.78
Total Liabilities
692.6689.35457.43533.67587.31812.06

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
748.28748.28717.92677.1661.9661.9
Additional Paid-In Capital
-960.31844.08700.34648.26638.12
Retained Earnings
209.27272.47335.25249.73201.61150.72
Treasury Stock
-123.01-----
Comprehensive Income & Other
959.59-0.82-0.2-0.66-0.84-0.86
Shareholders' Equity
1,7941,9801,8971,6271,5111,450
Total Liabilities & Equity
2,4872,6702,3542,1602,0982,262

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
485.56485.13224.24347.91411.99633.09
Net Cash (Debt)
385.56440.57581.69397.09205.7462.75
Net Cash Growth
-18.65%-24.26%46.49%93.01%227.89%-31.96%
Net Cash Per Share
4.945.737.815.192.760.88
Filing Date Shares Outstanding
71.9874.8371.7967.7166.1966.19
Total Common Shares Outstanding
71.9874.8371.7967.7166.1966.19
Working Capital
731.71,253829.35858.92752.95499.6
Book Value Per Share
24.9226.4626.4224.0222.8321.90
Tangible Book Value
1,7921,9791,8951,6241,5081,446
Tangible Book Value Per Share
24.9026.4526.4023.9922.7921.85
Land
-4.734.734.734.739.5
Buildings
-689.26687.72686.59686.32688.54
Machinery
-1,031926.47909.63896.45891.02
Construction In Progress
-17.6820.573.54.620.77